Foundation Board Member Appointed to Federal Advisory Committee


For Immediate Release

San Francisco, April 12 – Carol L. Brosgart, MD, a member of San Francisco AIDS Foundation Board of Directors, has been appointed to the U.S. Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment (CHAC).  The committee gives guidance to the CDC Director and HRSA Administrator on prevention and control, health care, and education activities related to HIV/AIDS, viral hepatitis, and other STDs.

“Dr. Brosgart is well known as a leader in the field of infectious disease prevention and care in the United States and globally,” said Neil Giuliano, San Francisco AIDS Foundation CEO.  “Carol brings her early days as a public health physician and HIV/AIDS clinician and researcher, caring for people living with HIV/AIDS, to everything she does.  As we move to radically reduce new HIV infections in San Francisco, and ensure that individuals know their HIV status and are linked to comprehensive care, it is comforting to know that one of our local physician leaders will be contributing to national health policy.”

Dr. Brosgart has a long history of participating in, evaluating, and supporting clinical research.  She is currently chief medical officer at Alios BioPharma, where she is responsible for leading the company’s clinical drug development programs.  Previously, Dr. Brosgart served as senior vice president and chief medical officer at Children’s Hospital & Research Center Oakland, and as vice president, clinical research and vice president, public health and policy at Gilead Sciences.  Prior to Gilead, she worked for more than 20 years in clinical care, research and teaching at several medical centers in the Bay Area. Dr. Brosgart was one of the first physicians in the U.S. to treat patients with AIDS, while at the Alameda County Health Care Services Agency. She was the founding medical director at the East Bay AIDS Center at Alta Bates Summit Medical Center in Berkeley.

“Carol truly believes in evidence-based approaches to health care policy,” said Tom Perrault, chair of San Francisco AIDS Foundation Board of Directors.  “She has devoted much of her career to improving the health and well being of people living with chronic infectious diseases like HIV/AIDS, with great skill and understanding. And, she has been equally committed to HIV prevention efforts.”

Dr. Brosgart will serve a two-year term on the advisory committee.  The panel is made up of 18 members who are experts in the fields of public health, epidemiology, laboratory practice, immunology, infectious diseases, drug abuse, behavioral science, health education, and health care delivery.

About San Francisco AIDS Foundation
San Francisco AIDS Foundation works to ensure the HIV epidemic ends in the same city where it began. By combining innovative, evidence-based programs for HIV prevention and care with bold policy initiatives focused on issues ranging from harm reduction to total health and wellness, the agency is making sustainable progress against HIV among populations most vulnerable to the disease. Established in 1982, San Francisco AIDS Foundation refuses to accept that HIV transmission is inevitable.

###

Media Inquiries

Andrew Hattori
(415) 487-3071
ahattori (at) sfaf.org

San Francisco AIDS Foundation
1035 Market St
suite 400
San Francisco CA
94103